A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan
Clinical trial NCT07730489 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07730489
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-12-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.